Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. must have experienced bladder pain, urinary urgency and urinary frequency, for at least 6 months prior to entry into the study~2. Pain VAS ≥4~3. O'Leary-Sant Interstitial Cystitis questionnaire (IC-Q) symptom and problem ≥ 12( and pain ≥2, and nocturia ≥ 2)~4. PUF score ≥ 13~5. cystoscopic record within 2 years~6. Hunner ulcer lesion in cystoscopic finding~Exclusion Criteria:~1. Scheduled for or use of intravesical therapy (eg, bladder distention,transurethral resection of bladder ulcer, instillation) during or within 6months prior to the study and use of pentosan polysulfate sodium within 1 months prior to the study~2. Patients who are pregnancy or, childbearing age without no contraception~3. Patients with voided volume \<40 or, \> 400ml~4. Patients with microscopic hematuria, (≥1+ in dipstick), If not excluded that no evidence of neoplastic tumor examination~5. Patients with urine culture showing evidence of urinary tract infection 1month prior to the study~6. Accompanied medical problem below~   * Tuberculosis in urinary system~  * Bladder cancer, urethral cancer, prostate cancer~  * Recurrent cystitis~  * anatomical disorder~7. Patients had prior surgery (eq, bladder augmentation, cystectomy~8. Patients with neurologic disorder~9. Patients with indwelling catheter or intermittent self-catheterization~10. Patients with psychologic problem

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Additional instillation of hyaluronic acid/chondroitin sulfate (Type: EXPERIMENTAL): Transurethral resection of bladder ulcer + instillation of hyaluronic acid/chondroitin sulfate
- Transurethral resection of bladder ulcer (Type: ACTIVE_COMPARATOR): Transurethral resection of bladder ulcer

Based on this trial design, predict the completion outcome and termination type (if applicable).